CUTANEOUS CORTICOSTEROID THERAPY AND CATARACT IN MAN

REFERENCES

• Barnetson R.S., White A.D. The Use of Corticosteroids in Dermatological Practice. Med. J. Aust. 1992; 156: 428–431
   PubMed Web of Science ®Google Scholar
• Wester R.C., Maibach H.I. Percutaneous Absorption of Topical Corticosteroids. Curr. Probl. Dermatol. 1993; 21: 45–60
   PubMedGoogle Scholar
• Branco N., Branco B.C., Maibach H.I. Cutaneous Corticosteroid Induced Glaucoma. J. Toxicol.—Cut. Ocular Toxicol. 2002; 21(1-2)1–7
   Google Scholar
• Bouzas E.A., Mastorakos G., Friedman T.C., Scott M.H., Chrousos G.P., Kaiser-Kupfer M.I. Posterior Subcapsular Cataract in Endogenous Cushing Syndrome: An Uncommon Manifestation. Investig. Ophthalmol. Vis. Sci. 1993; 34: 3497–3500
   PubMed Web of Science ®Google Scholar
• Furst C., Smiley W.K., Ansell B.M. Steroid Cataract. Ann. Rheum. Dis. 1966; 25: 364–368
   PubMed Web of Science ®Google Scholar
• David D.S., Berkowitz J.S. Ocular Effects of Topical and Systemic Corticosteroids. Lancet 1969; 2: 149–151
   PubMed Web of Science ®Google Scholar
• Urban R.C., Jr., Cotlier E. Corticosteroid-Induced Cataracts. Surv. Ophthalmol. 1986; 31: 102–110
   PubMed Web of Science ®Google Scholar
• Crews S. Posterior Subcapsular Lens Opacities in Patients on Longterm Corticosteroid Therapy. Br. Med. J. 1963; 53: 1644
   Google Scholar
• Giles C.L., Maison G.L., Dugg I.F., et al. The Association of Cataract Formation and Systemic Corticosteroid Therapy. J. Am. Med. Assoc. 1962; 182: 719–722
   Web of Science ®Google Scholar
• Suie T., Taylor F.W. The Effect of Cortisone on Experimental Pseudomonas Corneal Ulcers. Arch. Ophthalmol. 1956; 56: 53
   Web of Science ®Google Scholar
• Phillips C.I., Donnelly C.A., Clayton R.M., Cuthbert J. Skin Disease and Age-Related Cataract. Acta Dermatol. Venereol. 1996; 76: 314–318
   PubMed Web of Science ®Google Scholar
• Fritz K.A., Weston W.L. Topical Glucocorticosteroids. Ann. Allergy 1983; 50: 68–76
   PubMedGoogle Scholar
• Gruber G.G., Callen J.P. Systemic Complications of Commonly Used Dermatologic Drugs. Cutis 1978; 21: 825–829
   PubMed Web of Science ®Google Scholar
• Shiono H., Oonishi M., Yamaguchi M., Sakamoto F., Umetsu A. Posterior Subcapsular Cataracts Associated with Long-Term Oral Corticosteroid Therapy. Ophthalmologic Observations Indicate These Are Frequent Though Clinically Unsuspected. Clin. Pediatr. (Phila.) 1977; 16: 726–728
   PubMed Web of Science ®Google Scholar
• Munjal V.P., Dhir S.P., Jain I.S., Gangwar D.N., D'Souza M. Topical Corticosteroids and Cataract. Indian J. Ophthalmol. 1984; 32: 478–480
   PubMedGoogle Scholar
• Ng J.S., Wong W., Law R.W., Hui J., Wong E.N., Lam D.S. Ocular Complications of Paediatric Patients with Nephrotic Syndrome. Clin. Exp. Ophthalmol. 2001; 29: 239–243
   PubMed Web of Science ®Google Scholar
• Jick S.S., Vasilakis-Scaramozza C., Maier W.C. The Risk of Cataract Among Users of Inhaled Steroids. Epidemiology 2001; 12: 229–234
   PubMed Web of Science ®Google Scholar
• Jobling A.I., Stevens A., Augusteyn R.C. Binding of Dexamethasone by Alpha-Crystallin. Investig. Ophthalmol. Vis. Sci. 2001; 42: 1829–1832
   PubMed Web of Science ®Google Scholar
• Babizhaev M.A. Accumulation of Lipid Peroxidation Products in the Human Lens During Cataract Maturation. Vopr. Med. Khim 1985; 31: 100–104
   PubMedGoogle Scholar
• Dickerson J.E., Jr., Dotzel E., Clark A.F. Steroid-Induced Cataract: New Perspective from In Vitro and Lens Culture Studies. Exp. Eye Res. 1997; 65: 507–516
   PubMed Web of Science ®Google Scholar
• Mannis M., Macsai M., Huntley A. Eye and Skin Disease. Lippincott-Raven, Philadelphia 1996
   Google Scholar
• Garrity J.A., Liesegang T.J. Ocular Complications of Atopic Dermatitis. Can. J. Ophthalmol. 1984; 19: 21–24
   PubMed Web of Science ®Google Scholar
• Amemiya T., Matsuda H., Uehara M. Ocular Findings in Atopic Dermatitis with Special Reference to the Clinical Features of Atopic Cataract. Ophthalmologica 1980; 180: 129–132
   PubMed Web of Science ®Google Scholar
• Sehgal V.N., Jain S. Atopic Dermatitis: Ocular Changes. Int. J. Dermatol. 1994; 33: 11–15
   PubMed Web of Science ®Google Scholar
• Castrow F.F., 2nd. Atopic Cataracts Versus Steroid Cataracts. J. Am. Acad. Dermatol. 1981; 5: 64–66
   PubMed Web of Science ®Google Scholar
• Rich L.F., Hanifin J.M. Ocular Complications of Atopic Dermatitis and Other Eczemas. Int. Ophthalmol. Clin. 1985; 25: 61–76
   PubMedGoogle Scholar
• Katsushima H., Miyazaki I., Sekine N., Nishio C., Matsuda M. Incidence of Cataract and Retinal Detachment Associated with Atopic Dermatitis. Nippon Ganka Gakkai Zasshi 1994; 98: 495–500
   PubMedGoogle Scholar
• Rosen E. Atopic Cataract. Charles C Thomas, Springfield, IL 1959; 8–15
   Google Scholar
• Niwa Y. Oxidative Injury and Its Defense System In Vivo. Rinsho Byori 1999; 47: 189–209
   PubMedGoogle Scholar
• Smolin G., O'Connor G.R. Ocular Immunology. Lea & Febiger, Philadelphia 1981
   Google Scholar
• Brunsting L.A., Reed W.B., Bair H.L. Ocurrence of Cataracts and Keratoconus with Atopic Dermatitis. Arch. Dermatol. 1955; 72: 237–241
   Web of Science ®Google Scholar
• Renfro L., Snow J.S. Ocular Effects of Topical and Systemic Steroids. Dermatol. Clin. 1992; 10: 505–512
   PubMed Web of Science ®Google Scholar
• Braver D.A., Richards R.D., Good T.A. Posterior Subcapsular Cataracts in Corticosteroid-Treated Children. J. Pediatr. 1966; 69: 735–738
   PubMed Web of Science ®Google Scholar
• Forman A.R., Loreto J.A., Tina L.U. Reversibility of Corticosteroid-Associated Cataracts in Children with the Nephrotic Syndrome. Am. J. Ophthalmol. 1977; 84: 75–78
   PubMed Web of Science ®Google Scholar
• Skalka H.W., Prchal J.T. Effect of Corticosteroids on Cataract Formation. Arch. Ophthalmol. 1980; 98: 1773–1777
   PubMed Web of Science ®Google Scholar
• Loredo A., Rodriguez R.S., Murillo L. Cataracts After Short-Term Corticosteroid Treatment. N. Engl. J. Med. 1972; 286: 160
   PubMed Web of Science ®Google Scholar
• Rooklin A.R., Lampert S.I., Jaeger E.A., McGeady S.J., Mansmann H.C., Jr. Posterior Subcapsular Cataracts in Steroid-Requiring Asthmatic Children. J. Allergy Clin. Immunol. 1979; 63: 383–386
   PubMed Web of Science ®Google Scholar
• Costagliola C., Cati-Giovannelli B., Piccirillo A., Delfino M. Cataracts Associated with Long-Term Topical Steroids. Br. J. Dermatol. 1989; 120: 472–473
   PubMed Web of Science ®Google Scholar
• Aggarwal R.K., Potamitis T., Chong N.H., Guarro M., Shah P., Kheterpal S. Extensive Visual Loss with Topical Facial Steroids. Eye 1993; 7: 664–666
   PubMed Web of Science ®Google Scholar
• McLean C.J., Lobo R.F., Brazier D.J. Cataracts, Glaucoma, and Femoral Avascular Necrosis Caused by Topical Corticosteroid Ointment. Lancet 1995; 345: 330
   PubMed Web of Science ®Google Scholar